EX-10.4 5 a15-23793_1ex10d4.htm EX-10.4 CERTAIN MATERIAL (INDICATED BY [***]) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE...Transitional Supply Agreement • May 5th, 2020
THIS TRANSITIONAL SUPPLY AGREEMENT (this “Supply Agreement”) is made as of April 2, 2015 (the “Effective Date”) by and among Janssen Ortho LLC, a Delaware limited liability company located at Bo. Mamey, Carr. 933 Km 0., Gurabo, Puerto Rico 00778-9629, United States, Janssen Pharmaceuticals, Inc. (individually referred to as “Seller” and, together with Janssen Ortho LLC, “Manufacturer”), a Pennsylvania corporation located at 1125 Trenton-Harbourton Road, Titusville, NJ 08560 and Depomed, Inc. (the “Purchaser”), a California corporation located at 7999 Gateway Boulevard, Suite 300, Newark, CA 94560. Manufacturer and Purchaser are individually referred to as a “Party” and collectively as the “Parties,” as the context may require.
FIRST AMENDMENT TO TRANSITIONAL SUPPLY AGREEMENTTransitional Supply Agreement • August 11th, 2006 • Warner Chilcott Holdings CO III, LTD • Pharmaceutical preparations
This First Amendment to Transitional Supply Agreement (“Amendment”) is entered into effective as of July 1, 2006 between Warner Chilcott Company, Inc., a Company organized under the laws of the Commonwealth of Puerto Rico (“Supplier”), and Pfizer Inc., a Delaware corporation (“Pfizer”).
EXHIBIT 1.45Transitional Supply Agreement • March 27th, 1998 • Aurora Foods Inc • Miscellaneous food preparations & kindred products • Ohio
RECITALSTransitional Supply Agreement • December 31st, 2003 • Galen Holdings PLC • Pharmaceutical preparations • New York
